Impact of Azygos Venous Pathway Status on Surgical Difficulty in RCC

Overview

Revise to emphasize the predictive value of AVP quantification for intraoperative bleeding risk.

Background

Renal cell carcinoma (RCC) is a highly vascularized malignancy that often leads to the formation of venous tumor thrombus (VTT), complicating surgical interventions. The management of VTT through radical nephrectomy and tumor thrombectomy is associated with significant intraoperative hemorrhage, necessitating improved preoperative planning. Understanding the role of collateral venous pathways, particularly the AVP, is crucial for optimizing surgical outcomes and minimizing complications.

Data Highlights

No numerical data available in the provided text.

Key Findings

• The prevalence of venous tumor thrombus in RCC patients ranges from 4-10%.
• Intraoperative blood loss during radical nephrectomy and tumor thrombectomy can reach up to 7000 ml.
• Temporary clamping of the AVP may reduce intraoperative bleeding during surgery.
• Preoperative imaging of the AVP can help identify patients at high risk for massive hemorrhage.
• Previous studies indicate that collateral venous routes can significantly influence surgical complexity and bleeding risk.

Clinical Implications

Clinicians should consider the status of the azygos-hemiazygos pathway during preoperative assessments for patients with RCC and VTT. Implementing strategies such as temporary AVP clamping may enhance surgical safety by mitigating the risk of excessive intraoperative bleeding.

Conclusion

Strengthen the conclusion by explicitly stating the potential benefits of AVP assessment.

References

1. Hao et al., Peking University Third Hospital, 2023 -- Impact of Azygos Venous Pathway Status on Surgical Difficulty in RCC
2. Olivero et al., 2023 -- Minimally Invasive Surgical Approaches for Adrenocortical Carcinoma with Venous Invasion
3. 2024 EAU Guidelines on RCC -- DISEASE MANAGEMENT
4. Impact of Left Renal Vein Division on Renal Function and the Role of the Communicating Lumbar Vein in Juxtarenal Aortic Surgery
5. Effectiveness of Immune Checkpoint Inhibitors in Reducing Venous Tumor Thrombus in Renal Cell Carcinoma (UroCCR 128)
6. EAU Guidelines on RCC - DISEASE MANAGEMENT
7. Circumferential Inferior Vena Cavectomy Without Caval Replacement in the Management of Renal Cell Carcinoma with Tumor Thrombus | Current Urology Reports | Springer Nature Link
8. Neoadjuvant toripalimab plus axitinib for clear cell renal cell carcinoma with inferior vena cava tumor thrombus: NEOTAX, a phase 2 study | Signal Transduction and Targeted Therapy